Leverage Our Deep Experience in Oncology

Address Oncology's Unmet Needs with Innovative Strategies

Despite the volume of research, oncology remains among the diseases with the highest unmet patient needs. Study failure rates are high, often attributed to the fact that cancer is a disease of multiple pathophysiologies, many of which are not yet fully characterized, the novel nature of the treatments, and the challenges of accessing patients for research.  

We can help you mitigate these challenges to reveal the full potential of your therapy. We leverage our comprehensive, industry-leading toolkit in innovative trial designs and advanced predictive analytics, together with extensive global networks for access to patient data, and our Axio® Data Monitoring Committee services to enhance the efficiency and effectiveness of oncology trials. 

Our expertise with data and evidence is crucial in a field with such wide-ranging manifestations of disease. 

In particular, real-world evidence and its related methodologies are key quantitative strategies for responding to critical needs within therapeutic development for oncology, including: 

• Overcoming the hurdles of small sample sizes 
• The demand for heightened patient safety
• Ensuring that the critically ill receive therapies quickly and efficiently
• The expectation that after a trial is over and submission is accepted the therapy will be widely accessible through commercial viability 
• Understanding patient preferences for different types of therapies and/or formulations